INSIGHTS ON CLINICAL TRIAL PARTNERING

• Accelerating Parkinson's Disease Clinical Research Through CHDR's Monocentre Recruitment Capabilities

  Centralized PD trials reduce variability, accelerate enrolment, and enable genetic stratification for targeted therapies. This streamlined model delivers high-quality data and faster timelines, helping sponsors move confidently from early-phase research to late-stage development.

• Muscular Dystrophy: Multi-National And Multi-Site Trials

  Learn about the success ReveraGen found when expanding their partnership with Novotech to a larger phase 2b trial (VBP15-004) in Duchenne Muscular Dystrophy (DMD).

• Reframing Vendor Selection: Beyond Price And Past Relationships

  An RFP is more than a budget tool — it’s a strategic communication document that guides vendors, clarifies expectations, and enables informed, data-driven sponsor decisions.

• Overcoming Unexpected Obstacles In A Phase 1 Study

  Discover how the implementation of mobile vision clinics (MVCs) was used to enhance efficiency in a Phase 1 clinical trial.

• Operational Excellence In An International Clinical Research Site Network

  5/13/2025

  This case study highlights operational excellence within a global clinical trial for osteoporosis, underscoring the critical role of site networks in achieving research success.

• 10 Roadblocks To Traditional Vendor Selection And How ClinAI Solves Them

  7/1/2025

  Vendor selection in clinical trials is a pivotal process. Explore ten widespread inefficiencies in the current approach and how you can resolve them.

• Addressing A Global Health Priority In Australia And New Zealand

  11/7/2025

  For sponsors navigating a competitive therapeutic landscape, this case underscores how regional execution excellence can accelerate global impact.

• EHR-To-EDC: Choosing The Right Solution For Clinical Trials

  12/13/2024

  Here we highlight key advantages of EHR-to-EDC eSource, such as cost-effectiveness and improved site satisfaction.

• Critical Imaging Risks In GLP-1 And Neurology Studies

  4/3/2025

  In the evolving landscape of GLP-1 and neurology clinical trials, imaging has become a pivotal tool for evaluating both efficacy and safety. Delve into the early indicators of imaging-related challenges and insights into preclinical strategies for effective risk mitigation.